Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers.

Kunos CA, Chu E, Makower D, Kaubisch A, Sznol M, Ivy SP.

Front Oncol. 2017 Apr 4;7:62. doi: 10.3389/fonc.2017.00062. eCollection 2017.

2.
3.

Phase I trial of daily triapine in combination with cisplatin chemotherapy for advanced-stage malignancies.

Kunos CA, Chu E, Beumer JH, Sznol M, Ivy SP.

Cancer Chemother Pharmacol. 2017 Jan;79(1):201-207. doi: 10.1007/s00280-016-3200-x. Epub 2016 Nov 22.

PMID:
27878356
4.

Radiation-Therapeutic Agent Clinical Trials: Leveraging Advantages of a National Cancer Institute Programmatic Collaboration.

Takebe N, Ahmed MM, Vikram B, Bernhard EJ, Zwiebel J, Norman Coleman C, Kunos CA.

Semin Radiat Oncol. 2016 Oct;26(4):271-80. doi: 10.1016/j.semradonc.2016.06.005. Epub 2016 Jun 15. Review.

PMID:
27619249
5.

Impact of nurse navigation on timeliness of diagnostic medical services in patients with newly diagnosed lung cancer.

Kunos CA, Olszewski S, Espinal E.

J Community Support Oncol. 2015 Jun;13(6):219-24. doi: 10.12788/jcso.0141.

PMID:
26270521
6.

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy.

Kunos CA, Fabien JM, Shanahan JP, Collen C, Gevaert T, Poels K, Van den Begin R, Engels B, De Ridder M.

J Vis Exp. 2015 Jun 7;(100):e52875. doi: 10.3791/52875.

7.

Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer.

Kunos CA, Sherertz TM, Mislmani M, Ellis RJ, Lo SS, Waggoner SE, Zanotti KM, Herrmann K, Debernardo RL.

Front Oncol. 2015 Jun 5;5:126. doi: 10.3389/fonc.2015.00126. eCollection 2015.

8.

Determination of triapine, a ribonucleotide reductase inhibitor, in human plasma by liquid chromatography tandem mass spectrometry.

Feng Y, Kunos CA, Xu Y.

Biomed Chromatogr. 2015 Sep;29(9):1380-7. doi: 10.1002/bmc.3434. Epub 2015 Feb 10.

PMID:
25677991
9.

Two-step procedure for evaluating experimentally induced DNA damage: Texas Red and Comet assays.

Ferris GJ, Shunkwiler LB, Kunos CA.

Methods Mol Biol. 2015;1249:183-91. doi: 10.1007/978-1-4939-2013-6_13.

PMID:
25348306
10.

Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer.

Viswanathan AN, Erickson B, Gaffney DK, Beriwal S, Bhatia SK, Lee Burnett O 3rd, D'Souza DP, Patil N, Haddock MG, Jhingran A, Jones EL, Kunos CA, Lee LJ, Lin LL, Mayr NA, Petersen I, Petric P, Portelance L, Small W Jr, Strauss JB, Townamchai K, Wolfson AH, Yashar CM, Bosch W.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):320-8. doi: 10.1016/j.ijrobp.2014.06.005.

11.

Hydration during breast radiotherapy may lower skin toxicity.

Kunos CA, Abdallah RR, Lyons JA.

Breast J. 2014 Nov-Dec;20(6):679-81. doi: 10.1111/tbj.12348. Epub 2014 Sep 23. No abstract available.

PMID:
25252223
12.

Long-Term Disease Control with Triapine-Based Radiochemotherapy for Patients with Stage IB2-IIIB Cervical Cancer.

Kunos CA, Sherertz TM.

Front Oncol. 2014 Jul 24;4:184. doi: 10.3389/fonc.2014.00184. eCollection 2014.

14.

Acute gastrointestinal toxicity after robotic stereotactic ablative radiotherapy for treatment of metastatic gynecological malignancies.

Mislmani M, Frasure H, Suppiah S, Fabien J, Lo SS, Debernardo R, Kunos CA.

Future Oncol. 2014 Feb;10(2):241-8. doi: 10.2217/fon.13.215.

PMID:
24490610
15.
16.

Cabazitaxel-induced stabilization of microtubules enhances radiosensitivity in ovarian cancer cells.

Kunos CA, Stefan T, Jacobberger JW.

Front Oncol. 2013 Sep 18;3:226. doi: 10.3389/fonc.2013.00226. eCollection 2013.

17.

Role of stereotactic radiosurgery in gynecologic cancer.

Kunos CA, Spelic M.

Curr Opin Oncol. 2013 Sep;25(5):532-8. doi: 10.1097/CCO.0b013e328363e0ad. Review.

PMID:
23942297
18.

Radiation quality, like art, consists in drawing the line somewhere.

Kunos CA, Petersen IA.

Front Oncol. 2013 Jul 17;3:163. doi: 10.3389/fonc.2013.00163. eCollection 2013.

19.

Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.

Kunos CA, Radivoyevitch T, Waggoner S, Debernardo R, Zanotti K, Resnick K, Fusco N, Adams R, Redline R, Faulhaber P, Dowlati A.

Gynecol Oncol. 2013 Jul;130(1):75-80. doi: 10.1016/j.ygyno.2013.04.019. Epub 2013 Apr 18.

20.

Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer.

Berber B, Sanabria JR, Braun K, Yao M, Ellis RJ, Kunos CA, Sohn J, Machtay M, Teh BS, Huang Z, Mayr NA, Lo SS.

Expert Rev Anticancer Ther. 2013 Apr;13(4):481-7. doi: 10.1586/era.13.19. Review.

PMID:
23560842

Supplemental Content

Loading ...
Support Center